Literature DB >> 27278239

Ascites in Children.

Ashish Bavdekar1, Nitin Thakur2.   

Abstract

Ascites is an accumulation of serous fluid within the peritoneal cavity. It is the most common complication of liver cirrhosis. In children, hepatic, renal and cardiac disorders are the most common causes. Portal hypertension and sodium and fluid retention are key factors in the pathophysiology of ascites. Peripheral arterial vasodilatation hypothesis is the most accepted mechanism for inappropriate sodium retention and formation of ascites. Diagnostic paracentesis is indicated in children with newly diagnosed ascites and in children with suspected complications of ascites. Ascitic fluid is evaluated for cell count, protein level, and culture. The serum-ascites albumin gradient (SAAG) is the best single test for classifying ascites into portal hypertensive (SAAG >1.1 g/dl) and non-portal hypertensive (SAAG <1.1 g/dl). A neutrophil count ≥250 cells/mm3 is highly suggestive of bacterial peritonitis. The treatment of ascites due to non-liver disease depends on the underlying condition. In liver disease, diuretics as monotherapy or dual therapy and salt restriction form the mainstay of treatment in children with mild to moderate ascites. Fluid restriction is helpful in children with hyponatremia. In non-responsive ascites or in children with large ascites, large volume paracentesis (LVP) with albumin infusion should be performed. In children with refractory ascites, LVP with albumin administration, transjugular intrahepatic porto-systemic shunt (TIPS), peritoneo-venous shunting and liver transplantation are other therapeutic modalities that need to be considered.

Entities:  

Keywords:  Ascites; Child; Cirrhosis; Diagnosis; Management

Mesh:

Year:  2016        PMID: 27278239     DOI: 10.1007/s12098-016-2168-1

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  24 in total

Review 1.  Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club.

Authors:  A Rimola; G García-Tsao; M Navasa; L J Piddock; R Planas; B Bernard; J M Inadomi
Journal:  J Hepatol       Date:  2000-01       Impact factor: 25.083

Review 2.  EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.

Authors: 
Journal:  J Hepatol       Date:  2010-06-01       Impact factor: 25.083

Review 3.  The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.

Authors:  Thomas D Boyer; Ziv J Haskal
Journal:  Hepatology       Date:  2005-02       Impact factor: 17.425

4.  Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis.

Authors:  Gennaro D'Amico; Angelo Luca; Alberto Morabito; Roberto Miraglia; Mario D'Amico
Journal:  Gastroenterology       Date:  2005-10       Impact factor: 22.682

Review 5.  Should albumin be used in all patients with spontaneous bacterial peritonitis?

Authors:  Neeraj Narula; Keith Tsoi; John K Marshall
Journal:  Can J Gastroenterol       Date:  2011-07       Impact factor: 3.522

6.  A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites.

Authors:  Agustín Albillos; Rafael Bañares; Mónica González; María-Vega Catalina; Luis-Miguel Molinero
Journal:  J Hepatol       Date:  2005-07-05       Impact factor: 25.083

7.  Large-volume paracentesis in the management of ascites in children.

Authors:  R E Kramer; R J Sokol; B Yerushalmi; E Liu; T MacKenzie; E J Hoffenberg; M R Narkewicz
Journal:  J Pediatr Gastroenterol Nutr       Date:  2001-09       Impact factor: 2.839

8.  Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.

Authors:  Javier Fernández; Miquel Navasa; Juliá Gómez; Jordi Colmenero; Jordi Vila; Vicente Arroyo; Juan Rodés
Journal:  Hepatology       Date:  2002-01       Impact factor: 17.425

9.  Spontaneous bacterial peritonitis in children with chronic liver disease: clinical features and etiologic factors.

Authors:  V F Larcher; N Manolaki; A Vegnente; D Vergani; A P Mowat
Journal:  J Pediatr       Date:  1985-06       Impact factor: 4.406

10.  Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system.

Authors:  R M Pérez-Ayuso; V Arroyo; R Planas; J Gaya; F Bory; A Rimola; F Rivera; J Rodés
Journal:  Gastroenterology       Date:  1983-05       Impact factor: 22.682

View more
  1 in total

1.  Hepatic Inflammatory Myofibroblastic Tumor Detected in the Fetal Period That Caused an Oncologic Emergency.

Authors:  Hirotaka Kato; Yasuyuki Mitani; Taro Goda; Masaki Ueno; Shinya Hayami; Hiroshi Tsujimoto; Shinji Kounami; Takayuki Ichikawa; Hiroki Yamaue
Journal:  Case Rep Oncol       Date:  2020-12-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.